HER3-Targeted Antibody-Drug Conjugate Shows Promise for Treatment-Resistant Solid Tumors
@ascocancer.bsky.social
oncodaily.com/insight/anti...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADC #HER3 #SolidTumors #NSCLC #LungCancer #DB1310 #ASCO #ASCO2025